Oligodendroglioma (patient information)
For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Jinhui Wu, MD
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview of oligodendroglioma
Oligodendroglioma is a type of glioma. It occupies about 4% of brain tumors. This type of brain tumor origins from the oligodendrocytes which make myelin, a substance that surrounds and insulates axons of the brain and spinal cord. Oligodendroglioma occurs primarily in adults and only rarely found in children. Usual symptoms include headache, hydrocephalus, nausea and vomiting, seizure, weakness, or numbness in the extremities. Sometimes oligodendroglioma may spread along the cerebrospinal fluid pathways but rarely spread outside the brain or spinal cord. Treatments include surgery, radiation therapy, chemotherapy, gene therapy, or a combination of them. Because oligodendroglioma may infiltrate nearby brain tissue, it cannot be completely removed by surgery. Prognosis of oligodendroglioma depends on the grade of the cancer.
See also
Where to find medical care for oligodendroglioma?
Directions to Hospitals Treating oligodendroglioma